Dencora Group

Dencora Group is a prominent property development and investment company based in the United Kingdom, specifically focused on the East Anglia and Cambridge regions. While not a drug development company itself, Dencora is a critical player in the life sciences sector as a developer of specialized laboratory and research infrastructure, including facilities at the Cambridge Science Park. The company gained significant biotech industry recognition as a founding investor in Quotient BioResearch, a major contract research organization (CRO) formed through the acquisition of the Horseracing Forensic Laboratory (HFL). Dencora continues to support the healthcare and biotechnology ecosystems by providing high-specification real estate solutions tailored to the needs of pharmaceutical and R&D firms.